(amino acids 329-379). cDNAs encoding full-length Kir2.2 and Kir2.2∆3 were subcloned into the pcDNA1 as described (18) . cDNAs encoding α1-, β1-, and β2-syntrophin were subcloned into pGW1.
Preparation of Affigel-GST-Kir2.2 affinity matrix -BL21 E. coli expressing either GST, GST-Kir2.2, or GST-Kir2.2∆3 fusion proteins (6) were pelleted and resuspended in 40 ml HNG (20 mM Hepes, pH 7.4, 1 mM EDTA, 1 mM EGTA, 1 mM MgCl 2 , 150 mM NaCl, 10% glycerol, 1 mM PMSF, 1X protease inhibitor cocktail) plus 1% Triton X-100 on ice. Cells were lysed with a French press. The lysate was centrifuged at 16,000 x g for 10 min. Two mls packed glutathione-agarose beads were added to the supernatant and incubated 30 min at 4°C while rotating. Beads were pelleted and the supernatant removed, followed by washing the beads three times, once with HNG plus 1% Triton X-100 and twice with HNG. Bound GST fusion proteins were eluted from beads by the addition of 20 mM glutathione (Sigma). Eluted proteins were then dialyzed against 200 volumes 1X PBS overnight at 4°C. To prepare affinity columns, 5 mg purified GST-fusion protein was incubated with 1 ml packed Affigel-10 (Bio-Rad) overnight at 4˚C according to manufacturer's instructions. To remove uncrosslinked fusion protein, the Affigel-10/GST fusion protein matrix was transferred to a column and washed consecutively with 20 volumes Buffer C (50 mM Hepes pH 7.6, 125 mM NaCl, 20% glycerol, 1 mM EDTA, 1 mM EGTA, 1 mM DTT), 20 volumes Buffer C with 2.5 M urea, 20 volumes Buffer C with 4 M urea, 10 volumes Buffer D with 1% Triton X-100, and finally 10 volumes Buffer D with 1 mM 1% Triton X-100, supplemented with 2 mg/ml competitive peptide (ERPYRRESEI) for 1 hr, followed by elution with Buffer D containing 1% SDS. Eluted proteins were precipitated with 20% trichloroacetic acid, washed with -20°C acetone, and dried with centrifugation under vacuum. Dried proteins were either used directly for mass spectrometry analysis (see below) or resuspended in 1X SDS sample buffer and separated by SDS-PAGE. Gels were either silver stained (Silver Stain Plus, Bio-Rad) or transblotted to Hybond ECL nitrocellulose membranes (Amersham Pharmacia Biotech) and incubated with primary antibodies followed by peroxidaseconjugated secondary antibodies. Immunoreactive proteins on membranes were detected by incubation with Supersignal West Dura enhanced chemiluminescent substrate (Pierce) followed by exposure to X-ray film.
Affinity chromatography for N-terminal microsequencing -Brain extract was subjected to the purification scheme described above, but scaled up ten times. Purified proteins were separated by SDS-PAGE, and transferred to Hybond-P (Amersham Pharmacia Biotech) polyvinylidene fluoride (PVDF) membrane. Proteins transferred to PVDF were stained with Coomassie blue, air dried and the desired protein bands were excised and amino terminal protein microsequencing was performed by automated Edman degradation (Proseq Inc.).
Multidimensional high pressure liquid chromatography coupled with electrospray
ionization tandem mass spectrometry -The trichloroacetic acid precipitated sample was reduced and alkylated using Tris 2-carboxyethyl phosphine and iodoacetamide according to the methods of McCormack, et al. (14) . The sample was then sequentially digested with endoproteinase Lys-C (Roche Diagnostics) and sequencing grade soluble trypsin (Promega) to produce a large collection of peptide fragments (14) . The resulting peptide mixture was then separated and analyzed by multidimensional protein identification technology (MudPIT) which features a series of HPLC columns (reverse phase/strong cation exchanger/reverse phase) followed by electrospray ionization tandem mass spectrometry as described (15, 19) , with modifications as described in McDonald et. al. (17) . Tandem mass spectra were searched against the rat, mouse, and human translated genomic databases using the SEQUEST software algorithm (20, 21) .
Search results were filtered and grouped using the DTASelect program which generates a file in which peptides are matched to a genetic locus (22) and identifications confirmed through manual evaluation of spectra. Eluted proteins common to both the control (Kir2.2∆3) and experimental (Kir2.2) columns were subtracted using the Contrast algorithm which allows the comparison of two datasets from different mass spectrometry runs (22) . Common contaminants such as the GST fusion protein, keratin, hemoglobin, HSP70, and tubulin were also subtracted as nonspecific binding proteins.
GST fusion protein pulldown assay -Pulldown assays with GST fusion proteins were performed as described (6) using 10 mg heart extract (see above) and 10 µg GST fusion protein per pulldown.
COS-1 cell protein expression and co-immunoprecipitation -COS-1 cells were co-
transfected with α1-, β1-, or β2-syntrophin with Kir2.2 or Kir2.2∆3 utilizing FuGene 6 (Roche Molecular Biochemicals), and used for co-immunoprecipitation as described (18) .
Immunoaffinity purification -Syntrophin and associated proteins were purified from rat hindlimb muscle using mouse monoclonal anti-syntrophin 1351 immunoaffinity chromatography as previously described (23) .
Antibodies and antisera -Primary antibodies used include affinity purified rabbit polyclonal anti-Kir2.2 (6, 24) , mouse monoclonal anti-SAP97, anti-Mint1 antibody, and antidystrobrevin (BD Transduction Laboratories), mouse monoclonal anti-CASK antibody, anti-PSD-95 family antibody (pan-MAGUK; clone K28/86.2) and rabbit polyclonal anti-GluR1 (Upstate Biotechnology), rabbit polyclonal anti-SAP97 (PA-741, Affinity Bioreagents), rabbit polyclonal anti-Veli/MALS-1, 2 and 3 (Zymed), and mouse monoclonal anti-syntrophin 1351 (25) , mouse monoclonal anti-dystrophin (MANDRA1, Sigma), mouse monoclonal anti-β-dystroglycan (Novocastra), horseradish peroxidase-linked anti-GST antibody (Santa Cruz Biotechnolgy). The rabbit anti-abLIM antiserum generated against a GST-abLIM fusion protein (26) (generous gift from Dr. Tiansen Li) and rabbit anti-Pals2 antiserum generated against a GST-Pals2 fusion protein (27) (generous gift from Dr. Ben Margolis) were pre-absorbed against GST-Kir2.2 fusion protein linked to glutathione agarose prior to use in immunoblotting. Antirabbit IgG and anti-mouse IgG secondary antibodies conjugated to horseradish peroxidase (Amersham Pharmacia Biotech) were used where appropriate.
Immunofluorescence Microscopy -Mice were euthanized with CO 2 and sternomastoid muscles dissected and immediately flash frozen in isopentane. Muscle was mounted with Histoprep. 16 µm frozen sections were cut with a cryostat (Leica CM 1850) and transferred to charged microscope slides (Fisher Scientific). Sections were fixed with 100% methanol 10 min at -20°C, then were incubated in blocking buffer (3% BSA, 1% donkey serum, 1% goat serum in 
RESULTS:
Affigel-GST-Kir2.2 affinity chromatography specifically purifies and enriches Kir2-associated proteins -Previously, GST fusion protein affinity chromatography was used to identify the Kir2-associated proteins SAP97 and PSD-95 (6). To establish a large scale affinity chromatography approach for identification of Kir2-associated proteins, we covalently crosslinked Affigel-10 matrix to a GST-Kir2.2 C-terminal fusion protein (Kir2.2), and a control GSTKir2.2 fusion protein with the three C-terminal amino acids deleted (Kir2.2∆3) (Fig. 1A ).
Comparing proteins isolated by these columns should allow one to identify proteins that are specifically associated with the Kir2.2 C-terminal PDZ binding motif (E-S-E-I; Fig. 1A ). We incubated these matrices with detergent solubilized rat cerebellum extracts, washed the columns extensively, and eluted bound proteins by competition with an excess of the competitive peptide, which corresponds to final ten C-terminal amino acids of Kir2.2. Eluted Kir2.2-associated proteins were then analyzed and identified by a number of different methods: 1) subjecting the eluted protein mixture directly to multidimensional high pressure liquid chromatography coupled with electrospray ionization tandem mass spectrometry (HPLC-MS-MS) followed by protein database searching with identified peptide masses, 2) SDS-PAGE followed by transfer to PVDF membrane and identification of candidate proteins by microsequencing using N-terminal Edman degradation, 3) SDS-PAGE followed by transfer to nitrocellulose and probing the membrane with antibodies to candidate proteins (Fig. 1B) .
We employed control experiments to verify that our Kir2.2 columns could efficiently and specifically purify proteins from detergent solubilized rat cerebellum, a brain region in which Kir2.2 expression is high (28) (29) (30) (31) . Extracts were incubated with Affigel-linked GST, Kir2.2, or Kir2.2∆3 and eluted with the competitive peptide. Eluted proteins were then separated by SDS-PAGE and silver stained. Proteins that were specifically bound and eluted from the Kir2.2 column with the competitive peptide could easily be detected (Fig. 1C , silver stain, lane 4, arrowheads). These specific Kir2.2 binding proteins were not detected in eluates from the control GST or Kir2.2∆3 columns (Fig. 1C , silver stain, lanes 2 and 3). As a separate control for the specificity of the eluting peptide, a scrambled peptide encoding the same amino acids as the competitive peptide, but in a random order was used to elute protein isolated by the Kir2.2 column. None of the specific proteins eluted by the competitive peptide were eluted by the scrambled peptide (Fig. 1C , silver stain, lane 5). This shows that the competitive peptide specifically elutes proteins associated with the C-terminus of Kir2.2.
To demonstrate that the Affigel-Kir2.2 matrix could efficiently enrich known Kir2.2-interacting proteins (4, 6) , eluted fractions from columns were subjected to western blotting with anti-SAP97 antibodies. SAP97 was significantly and specifically enriched in competitive peptide eluates as was PSD-95, which is also recognized by the antibody (Fig. 1C, peptide elution, lane 4). No SAP97 or PSD-95 could be detected in peptide eluates from the GST or Kir2.2∆3 columns (Fig. 1C, peptide elution, lanes 2 and 3) . The scrambled peptide eluates from the Kir2.2 column contained barely detectable amounts of SAP97 (Fig. 1C , peptide elution, lane 5). Following peptide elution, the columns were then incubated with 1% SDS to elute the remaining bound proteins. No SAP97 or PSD-95 was detected in eluates from the control GST or Kir2.2∆3 columns (Fig. 1C, SDS elution, lanes 2 and 3) . Residual SAP97 bound to Kir2.2 not completely eluted by the competitive peptide was detectable in SDS eluates of this column ( 
Analysis of Kir2.2 affinity purified brain proteins by HPLC-MS-MS -Recent advances
in HPLC-MS-MS and development of computer software for the analysis of large peptide fragment data sets, coupled with the huge increase in available protein sequence databases has greatly improved our ability to analyze purified protein mixtures and complexes (see methods) (14) (15) (16) 19) . Affigel-Kir2.2 and Kir2.2∆3 affinity chromatography was performed with detergent solubilized rat brain extracts followed by specific elution with the competitive peptide. Fig. 2A depicts the silver stained SDS-PAGE of the proteins analyzed by mass spectrometry. Many bands are clearly visible, specifically eluting from the Kir2.2 column and not present in the Kir2.2∆3 column ( Fig. 2A arrows) . There are also a number of additional bands associated with both columns, most likely corresponding to proteins that bound non-specifically to the columns. are similar to one another in domain structure, with a single PDZ domain followed by SH3 and GK domains, but with significantly different N-termini. The PDZ domains of CASK, Dlg2, Dlg3, and Pals2 are class II PDZ domains, and unlike the PDZ domains of SAP97-like MAGUK proteins, they are predicted to be incapable of direct interaction with Kir2.2 Indeed, we recently have shown that CASK does not bind directly to the channel, but instead interacts with the channel through its tight association with SAP97 or Veli (18, 36, 37) .
Both Veli-1 and Veli-3 were identified with 29.2% and 27.9% sequence coverage, respectively. The Veli proteins contain a single N-terminal L27 domain followed by a single class I PDZ domain. In addition to known interactions of CASK, Dlg2, Dlg3, and Pals2 with the Veli L27 domain, the C-terminus of the NMDA receptor NR2B can interact with the Veli PDZ domain (38) .
Interestingly, we also identified the actin-binding LIM protein, which could provide a link of the channel to the actin cytoskeleton. 
Immunoblot analysis of Kir2.2 affinity purified brain proteins -Another method to
confirm that the Kir2-associated proteins that were identified by mass spectrometry are indeed positive identifications was western blot analysis of peptide eluates from both the Kir2.2 and Kir2.2∆3 columns with available antibodies (Fig. 2B) . In all cases that we tested, the immunoblot results confirmed the protein identifications from mass spectrometry. The ~140 kDa protein SAP97 was specifically eluted from the Kir2.2 columns in great abundance as expected.
It is likely that more than one splice variant is represented (several bands are observed in the input), but these variants were not resolved in the Kir2.2 eluate because of the abundance of purified SAP97 protein and their similar molecular masses. To identify Chapsyn-110, SAP102, and PSD-95 (also identified in Fig. 1C ), we used an antibody that recognizes all four PSD-95 related MAGUK proteins (pan-MAGUK). Four bands could be resolved on the western blot, with SAP97 migrating as a broad band at ~140 kD, Chapsyn-110 migrating at ~110 kD, SAP102 migrating at ~100 kD, and PSD-95 migrating at ~95 kD. The lower band at ~75 kDa is probably a PSD-95 breakdown product that is often observed with a PSD-95-specific antibody (data not shown). Two splice variants of CASK were distinguished with the monoclonal anti-CASK antibody (Fig. 2B ). Veli-1 and Veli-3 were present in abundance, whereas Veli-2 was barely detectable (Fig. 2B ). These data are consistent with the absence of Veli-2 identification via mass spectrometry. The presence of abLIM at ~75 kDa (probably the m-abLIM isoform (26)) was detected specifically in the eluate from the Kir2.2 column. Using antiserum to Pals2, a band at ~60 kDa corresponding to Pals2 was specifically eluted from the Kir2.2 column, supporting the mass spectrometry data. The upper bands on this blot in eluates from both the Kir2.2 and Kir2.2∆3 columns are cross immunoreactivity with GST fusion protein dimers (GST-Pals2 was used to make antiserum (27) ). The AMPA receptor, GluR1, which is abundant in brain and interacts with SAP97 (39), was not detected in these eluates by western blot or mass spectrometry. This further supports the specificity of the affinity chromatography and the uniqueness of the complement of proteins isolated with the Kir2.2 column. Dlg2 and Dlg3 were not analyzed by western blotting due to lack of available antibodies.
We made probable assignments of the Kir2.2-specific band identities observed on the silver stained gels. Combining the predicted molecular mass data (Table 1 ) with known mobilities of the proteins identified by western blot (Fig. 2B ), approximate locations of proteins were aligned with specifically eluted bands ( Fig. 2A, arrows) . These protein band assignments are complicated by post translational modifications, unique protein folding characteristics, and alternative splicing forms, making some of the bands difficult to resolve on an SDS-PAGE. Fig.   2A shows that most of the proteins identified by mass spectrometry and immunoblotting can be correlated with silver stained bands in the correct vicinity of their molecular masses.
Analysis of Kir2.2 affinity purified heart proteins by HPLC-MS-MS -Non-neuronal
tissues contain unique types of channel-associated proteins that are not present in brain. Kir2 channels are particularly abundant in muscle including cardiac muscle and are likely to associate with proteins that are distinct from those in brain. To compare Kir2 channel-associated proteins identified in brain with proteins associated with the channels in cardiac tissue, we elected to perform Kir2.2 affinity chromatography using detergent solubilized heart samples. Isolated heart proteins were then subjected to mass spectrometry/Mudpit analysis as described above for purified brain proteins.
The purified heart proteins from Kir2.2 or Kir2.2∆3 columns were eluted with competitive peptide followed by a second elution with SDS. A fraction of the eluates were resolved by SDS-PAGE and silver stained. Proteins were detected that specifically were eluted from the Kir2.2 column and were not present in eluates from the control Kir2.2∆3 column (Fig.   3A ). Unlike the Kir2.2 interacting proteins purified from brain, specific cardiac Kir2.2 binding proteins were eluted both by the competitive peptide ( Fig. 3A) and also by the subsequent elution with SDS (Fig. 3B ). The proteins eluted by the peptide competition and SDS were then analyzed and identified by mass spectrometry as described above. Again, non-specific binding proteins were subtracted in the analysis, which defines specific proteins as those eluted from the Kir2.2 column, but not the Kir2.2∆3 column.
Analysis of heart proteins specifically eluted from the Kir2.2 column identified ten proteins (Tables 2 and 3 ). As in the brain, the proteins SAP97, Veli-1, Veli-3, and CASK were identified as Kir2.2-associated proteins in the heart (Table 2, 3, and Fig. 3C ). We also identified two peptides corresponding to the protein Mint1 in heart. This is a protein that associates with CASK and Veli in brain (40, 41) , but was not detected in our mass spectrometry analysis from brain. The presence of Mint1 in heart is a novel finding as previous reports described Mint1 as a neuronal-specific protein, with no Mint1 mRNA detected in heart by Northern blot analysis (42, 43) .
Previously unidentified Kir2.2-associated proteins that were purified from heart extracts by affinity chromatography and identified by mass spectrometry also include proteins of the dystrophin associated protein complex (DAPC): α1, β1, and β2 isoforms of syntrophin, dystrophin, and α-dystrobrevin (Tables 2 and 3 ). The DAPC forms a structural link between the actin cytoskeleton and extracellular matrix, and is particularly important in muscle cells where alterations in dystrophin can lead to muscular dystrophy (44) . Syntrophins are PDZ and pleckstrin homology domain-containing proteins that have been demonstrated as part of the DAPC. Two syntrophin-interacting proteins in the complex include dystrophin and dystrobrevin, both identified here as Kir2 channel-associated proteins.
Immunoblot analysis of Kir2.2 affinity purified heart proteins -To confirm that the Kir2-associated heart proteins that were identified by mass spectrometry are indeed positive identifications, we performed western blots on peptide as well as SDS eluates from both the Kir2.2 and Kir2.2∆3 columns with antibodies to the proteins (Fig. 3C) . By immunoblot we confirmed the identifications of SAP97, CASK, Veli-3, Mint1, three isoforms of syntrophin (mAb 1351 recognizes α1-, β1-and β2-syntrophin) , α-dystrobrevin-1, α-dystrobrevin-2, dystrophin and the dystrophin gene product Dp71. We detected the presence of Mint1 protein in peptide eluates, a new finding, as it was previously reported only to be neuronal (42, 43) . We detected Veli-3, but not Veli-1, in western blots using isoform specific anti-Veli antibodies, although both were identified by mass spectrometry (Fig. 3C and data not shown). These data agree with previous studies where the lower molecular mass Veli-3 protein is the predominant Veli expressed in heart (38, 40) . None of these proteins eluted from the Kir2.2∆3 columns, which indicates that the association with all of these proteins is mediated by the Kir2.2 PDZ binding motif.
To test for the presence of Kir2-associated proteins in brain that may have been missed by mass spectrometry, affinity-purified brain proteins were analyzed with antibodies to the DAPC and Mint1. When we probed these eluates with antibodies directed against protein components of the DAPC, we detected two isoforms of syntrophin, two isoforms of α-dystrobrevin, and two Dp71 isoforms of dystrophin (Fig. 4) . Upon immunoblot analysis, Mint1 protein was readily detected in Kir2.2 column eluates from brain (Fig. 4) . Mint1 is known to form a complex with CASK and Veli in brain (40, 41) , and our recent studies demonstrate that this complex is associated with Kir2 channels in brain and heart (18) . No DAPC proteins or Mint1 were detected in the control Kir2.2∆3 brain eluates, demonstrating that the intact PDZ binding motif is essential for their association with Kir2.2 (Fig. 4) . Therefore, Kir2 channels also associate with the DAPC and Mint1 in brain.
Differential protein association with other Kir channels -To determine whether other Kir channels containing C-terminal class I PDZ binding motifs, in addition to Kir2.2, could associate with the DAPC as well as SAP97, CASK and Veli, we performed affinity interaction assays.
GST-Kir fusion proteins were constructed with the C-terminal ~50 amino acid tails of Kir2.1 (PDZ binding motif: S-E-I), Kir2.2 (PDZ binding motif: S-E-I), Kir2.3 (PDZ binding motif: S-A-I) and Kir4.1 (PDZ binding motif: S-N-V). These GST fusion proteins were used in affinity pulldown assays with Triton X-100 solubilized heart and skeletal muscle extracts. In heart extracts, we readily detected syntrophin, α-dystrobrevin-2, and the Dp71 isoform of dystrophin in association with Kir2.2, Kir2.3, and Kir4.1 fusion proteins (Fig. 5, lanes 4, 6, and 7) , but not the controls GST and Kir2.2∆3 (Fig. 5, lanes 3, 1, and 5) . Association of syntrophin, α-dystrobrevin-2, and Dp71 with the Kir2.1 construct was detected with longer exposure times (data not shown). Additionally, the Kir4.1 construct pulled down the full length isoform of dystrophin (Fig. 5, lane 7) . To compare Kir channel association with other interacting proteins, we probed the same immunoblots for SAP97, CASK and Veli-3. Kir2.1, Kir2.2 and Kir2.3 fusion proteins all associated with these three proteins (Fig. 5, lanes 2, 3, and 5) ; however the Kir4.1 construct did not pull down detectable SAP97, CASK or Veli-3 (Fig. 5, lane 7) . We obtained similar results for affinity interaction assays using skeletal muscle extracts (data not shown).
These data demonstrate that each of these Kir channels can associate with scaffolding proteins, and that there is channel specificity in the interaction. Via their C-terminus, Kir4.1 channels associate with the DAPC; and Kir2.1, Kir2.2 and Kir2.3 channels can associate with both the DAPC as well as SAP97, CASK and Veli-3. These data imply that the C-terminal PDZ binding motifs of Kir channels confer specificity to their association with multicomponent protein complexes such as the DAPC and complexes containing SAP97, CASK, and Veli.
α1-, β1-and β2-syntrophin associate with Kir2.2 when co-expressed in a cellular environment -Because syntrophins contain class I PDZ domains capable of interacting with Cterminal ligands on sodium and water channels (45, 46) , we predicted that syntrophins and Kir2 channels should interact when expressed together in vivo. To determine whether Kir2.2 interacts with α1-, β1-and β2-syntrophin in a cellular environment, we expressed both proteins alone and in combination in COS-1 cells. Using an antibody against the N-terminus of Kir2.1/2.2, we immunoprecipitated Kir2.2 from COS-1 cell extracts. All three syntrophin isoforms coimmunoprecipitated with Kir2.2 (Fig. 6A, lanes 2, 5 and 8) . When α1-, β1-or β2-syntrophin was co-expressed with a mutant Kir2.2 construct with the last three C-terminal amino acids deleted (Kir2.2∆3), no syntrophin co-immunoprecipitation could be detected (Fig. 6A, lane 3, 6, and 9) .
Additionally, α1-, β1-or β2-syntrophin did not co-immunoprecipitate if Kir2.2 was not transfected (Fig. 6A, lane 1, 4, and 7) . Expression levels of Kir2.2, Kir2.2∆3, α1-, β1-and β2-syntrophin were comparable between transfections as indicated by immunoblotting a fraction of the immunoprecipitation inputs (Fig. 6A, lower panels) . This demonstrates that full length Kir2.2 can associate with α1-, β1-or β2-syntrophin in cells and the C-terminus of Kir2.2 encoding the PDZ binding motif is required for association.
Kir2 channels co-purify with syntrophin and the DAPC in the skeletal muscle -To determine whether Kir2 channels associate with the DAPC in a native setting, we performed immunoaffinity chromatography with a column composed of immobilized anti-syntrophin antibodies. Syntrophin and associated proteins were purified from detergent solubilized rat skeletal muscle extracts. Co-purification of Kir2.1/Kir2.2 with syntrophin was detected using the anti-Kir2.1/2.2 antibody (Fig. 6B, upper panel) . No Kir2 channels were detected when a control mouse IgG column was used for the purification (Fig. 6B, upper panel) . Co-purified channels may represent both Kir2.1 and Kir2.2, both of which are present in skeletal muscle.
Probing purified proteins from the same columns showed that other components of the DAPC, including dystrobrevin and β-dystroglycan co-purified with syntrophin, as shown previously (Fig. 6B lower panels and (23) ). This demonstrates that Kir2 channels associate with syntrophin and the DAPC in skeletal muscle.
Kir2.2 colocalizes with syntrophin, dystrophin, and dystrobrevin at neuromuscular
junctions -The DAPC is well known for its role in skeletal muscle where the complex provides mechanical stabilization of the plasma membrane during contraction and is involved in the formation and maintenance of the neuromuscular junction. In the absence of the normal complement of dystrophin, the sarcolemma may become damaged during contraction, leading to muscular dystrophy (44) . Since the C-terminus of Kir2.2 could readily associate with proteins of the DAPC, localization of Kir2.2 and the DAPC were examined in skeletal muscle where syntrophin, dystrophin, and dystrobrevin are known to be highly concentrated at neuromuscular junctions (NMJs). Immunofluorescence microscopy demonstrated that Kir2.2 was localized at NMJs in mouse sternomastoid muscle (Fig. 7, left panels) . Neuromuscular junctions were identified by labeling with α-bungarotoxin, a nicotinic acetylcholine receptor antagonist that labels the receptor-rich crests of the postsynaptic folds (Fig. 7, right panels) . Kir2.2 distribution partially colocalized with antibody labeling for syntrophin, dystrophin, and dystrobrevin (Fig. 7, middle panels), all of which were abundant at the NMJ (Fig. 7) . Colocalization with the DAPC proteins syntrophin, dystrophin, and dystrobrevin suggests that Kir2.2 interaction with the DAPC may be important to target, stabilize or anchor Kir2.2 at the NMJ.
DISCUSSION:
In this study, we have utilized affinity chromatography combined with a variety of protein identification techniques to demonstrate the association of nineteen different proteins with the C-terminal PDZ binding motif of Kir2.2 (Fig. 8) . To our knowledge, this is the first comprehensive proteomics study to identify proteins associated with a potassium channel. We verified that the previously identified Kir2.2 channel-associated proteins (PSD-95 and SAP97) could be enriched, purified, and identified by the techniques developed in this study (Fig. 1) (4, 6) . New channel-interacting proteins were identified here using affinity chromatography coupled with both HPLC-MS-MS and western blotting to confirm the identifications. All four members of the PSD-95 family of MAGUK proteins (PSD-95, SAP97, SAP102, and Chapsyn-110) in brain were found to associate with Kir2.2 whereas only SAP97 was identified from this group in heart. This is probably due to the very low or absent expression of PSD-95, SAP102, and Chapsyn-110 in heart. The proteins CASK, Mint1, and two isoforms of Veli (Veli-1 and Veli-3), which form a stable tripartite complex (40, 41, 47) , associated with the C-terminus of Kir2.2 with both brain and heart extracts. The biochemical composition and functional consequences of the channel association with SAP97, CASK, Mint1 and Veli are investigated in detail in the parallel study, where we show that a complex of these proteins is assembled with Kir2 channels in brain, and also demonstrate that a CASK-containing complex is involved in channel localization (18) . Other less well characterized MAGUK proteins, Dlg2, Dlg3, and Pals2 as well as actin-binding LIM protein were identified only in brain. An important novel finding of this study was that components of the dystrophin complex (α1, β1, and β2 syntrophin, dystrophin, Dp71, α-dystrobrevin-1 and α-dystrobrevin-2) associate with Kir2 channels proteins in heart, skeletal muscle and brain. Since most of these proteins are composed of modular protein-protein interaction domains (Fig. 8) , we conclude that Kir2 channels are associated with large complexes of proteins that may perform a variety of unique functions in channel trafficking and localization.
The proteins identified here are specific binding partners for the Kir2.2 C-terminus, which in some cases may also interact with the related channels Kir2.1, Kir2.3 and Kir4.1 (Fig.   5 ). Without exception, association with the channel C-terminus required the channel PDZ binding motif, and interactions were never observed in truncated channel constructs that lacked the C-terminal three amino acid motif. We were able to eliminate many nonspecific binding proteins by subtracting out proteins that bound to the Kir2.2∆3 control column, which was identical to the Kir2.2 column, but lacked the three C-terminal amino acids. Further specificity was obtained by eluting the columns with a competitive peptide encoding the final ten amino acids of Kir2.2. There are many other proteins expressed in brain and heart that contain class I PDZ domains that might have interacted with the Kir2 channel C-termini (48), but we did not detect specific binding by this method. For example, only the Veli-1 and Veli-3 isoforms were purified from brain, even though Veli-2 is also expressed in this tissue (18, 38, 49) . In early studies, we predicted that Kir2 channels may be linked to GluR1 AMPA receptors because both proteins interact with SAP97 (39). However, under these purification conditions we were not able to detect any GluR1 associated with Kir2.2. Taken together, these data indicate that the proteins purified on the Kir2.2 columns are specific binding partners for Kir2.2.
A variety of experiments shows that the proteins are functional interacting partners of the Kir2 channels in native tissues. In this study, and the parallel study (18) we describe the functional interactions of many of these proteins. We find that these proteins are associated with the channels when expressed in COS cells (SAP97, CASK, Mint1, Veli, PSD-95, syntrophin), that they co-immunoprecipitate with the channels in native tissues (SAP97, CASK, syntrophins), are colocalized with the channels in cultured cells and native tissues (SAP97, PSD-95, Veli, Mint1, syntrophin, dystrophin, dystrobrevin) and functionally regulate channel trafficking or membrane clustering (CASK, PSD-95) (5, 18) (D. Leonoudakis and C. Vandenberg, unpublished results). These associations will be described in more detail below with the individual proteins, and an in-depth study of SAP97, CASK, Mint1 and Veli in the parallel study (18) .
How are the proteins associated with the channel? Of these Kir2-associated proteins, nine proteins contain class I PDZ domains (PSD-95, SAP97, SAP102, Chapsyn-110, Veli-1, Veli-3, α1-syntrophin, β1-syntrophin, and β2-syntrophin) and we predict these interact directly with Kir2 C-termini. Indeed our parallel study demonstrates the ability of SAP97, Veli-1, and Veli-3 to directly interact with the Kir2.2 C-terminus (18) . These proteins with a class I PDZ domain likely act as the bridge to link the channel with other identified channel-interacting proteins that lack a class I PDZ domain.
PSD-95 is a well-studied membrane-associated MAGUK protein with a class I PDZ domain. PSD-95 is known for its roles in clustering ion channels and receptors (5, 32, 34) , postsynaptic targeting and localization due to dynamic palmitate modification (50-53), involvement in glutamatergic synaptic development (54) , and learning and memory formation (55) . PSD-95 and its homologous family members SAP97, SAP102, and Chapsyn-110 all contain three PDZ domains, followed by an SH3 domain and GK domain (Fig. 8) , with the second PDZ domain essential for interaction with the C-terminal PDZ binding motifs of ion channels and receptors.
We find that co-expression of Kir2. CASK also is classified as a MAGUK protein, but one which contains a single class II PDZ domain followed by an SH3 domain and GK domain (Fig. 8) . Since CASK contains a class II PDZ domain, it is unlikely to interact directly with the Kir C-terminus, and indeed we have shown that it can be recruited to the channel C-terminus by SAP97 or Veli (18) . Both SAP97 and CASK were demonstrated to interact in epithelial cells (36, 37) , and we have recently demonstrated that they form a stable complex with Kir2 channels in brain and heart (6, 18) .
Indeed, SAP97 and CASK colocalize with Kir2.2 and Kir2.3 channels (7, 18) , and a dominantnegative CASK construct results in Kir2.2 channel mislocalization in epithelial cells suggesting that a CASK-containing complex is involved in targeting Kir2.2 channels (18) . Since SAP97 and CASK are ubiquitously expressed, perhaps these proteins act together to influence Kir2 channel function in many different tissues. Indeed, targeted gene disruptions of SAP97 or CASK in mice result in the similar phenotype of cranial dysmorphogenesis and cleft palate (66, 67) providing genetic evidence for their functional association. CASK is known to form a complex with the proteins Veli and Mint1, and we found that all of these proteins were purified by Kir2.2 affinity chromatography (Table 1 and 2, Fig. 2, 3 and 4) . The evolutionarily conserved tripartite complex composed of CASK, Veli, and Mint1 is implicated in ion channel/receptor targeting and trafficking in both C. elegans epithelial cells (47) and mammalian neurons (68) . Since the CASK, Mint1 and Veli complex associates with a variety of channels and receptors (12, 47, 68) , the complex may play a general role in targeting and trafficking receptors and channels containing PDZ binding motifs.
The Veli proteins have a relatively simple domain structure with an N-terminal L27 domain fused to a Class I PDZ domain (Fig. 8) . The L27 domain has been shown to interact with N-terminal sequences of CASK-like MAGUK proteins and the PDZ domain interacts with NR2B NMDA receptors (38) and Kir2 channels (7, 18) . As well as forming a complex with CASK, Mint1, and SAP97 (18) , Veli proteins are involved in neuronal NMDA receptor trafficking and are implicated in the retention of channels and transporters in the plasma membrane, including the BGT-1 GABA transporter in epithelial cells and Kir2.3 channels expressed in Xenopus oocytes (7, 69) . Thus, it appears that Veli proteins may have different functional roles depending on the cellular context.
Mint1 is a protein that contains two PDZ domains near its C-terminus as well as other functional domains (Fig. 8) . Mint1 has be shown to interact with a variety of neuronal proteins including the motor protein KIF17 (68) , suggesting an interesting function to link cargo proteins to motor proteins for transport. Our finding that Mint1 associates with the Kir2.2 column in heart was unexpected. Previous reports of mRNA distribution characterized Mint1 as a protein expressed exclusively in neurons (42, 43) . However, mass spectrometry identified two proteolytic peptides from Mint1 (Table 2 ) and the identification was confirmed by immunoblot (Fig. 4) . This discovery implicates functional roles in cargo transport for Mint1 in non-neuronal tissues.
Three of the Kir2-interacting proteins from brain, Dlg2, Dlg3, and Pals2, are members of a CASK-like MAGUK protein family. Little is known about the function of these MAGUKs.
All three proteins have the same general domain organization as CASK with two L27 (L27N and L27C) domains at the N-terminus followed by a class II PDZ domain, an SH3, and GK domains (Fig. 8) . All three proteins can interact with Veli proteins via their L27C domain (27, 37, 40) .
The homology that these proteins display with CASK indicates that CASK, Dlg2, Dlg3, and Pals2 may associate with Kir2 channels in a similar manner. They probably do not interact directly with the channels, because the PDZ domains of these proteins will not recognize class I PDZ binding motifs, but like CASK, may be recruited by SAP97 or Veli (18) . Dlg2 and Dlg3 recently were shown to bind to SAP97 (70) , and these proteins contain L27 domains, which may interact with Veli proteins (27, 37) . No direct binding partners for the PDZ domains of Dlg2, Dlg3, and Pals2 have been described to date. It is possible that these proteins may be able to substitute for CASK, but target channel complexes differently. Additionally, the N-terminal domains of Dlg2, Dlg3, or Pals2 are unique, which increases the possible diversity of protein complexes with the channels. It is likely that these MAGUKs may assemble other, as yet unidentified proteins into a Kir2-associated complex.
An interesting Kir2-associated protein in brain is the actin-binding LIM protein, abLIM, which exists in three different isoforms, short, medium, and long. The protein has a multidomain structure composed of N-terminal LIM domains, a dematin-like domain, fused to a domain homologous to villin (26) . LIM domains are cysteine-rich zinc finger motifs first identified in homeodomain proteins involved in development and cellular differentiation, whereas other LIM-containing proteins have been found associated with the cytoskeleton (71).
The dematin-like domain/villin domain was demonstrated to facilitate binding of abLIM to Factin (26) . The association of this protein with Kir2 channels may link the channels to the actin cytoskeleton. It is unclear at this point how abLIM associates with the channels, but it is probably through another protein because abLIM does not contain a PDZ domain.
An intriguing group of novel Kir2-interacting proteins are the members of the dystrophinassociated complex (α1-, β1-, and β2-syntrophin, dystrophin, and dystrobrevin) . This is the first identification of members of the dystrophin complex associated with Kir2 channels. These proteins were identified by HPLC-MS-MS in heart extracts and confirmed in heart, skeletal muscle, and brain by immunoblotting. α1-, β1-, and β2-syntrophin are part of a family of proteins containing five isoforms that are known for their interactions with the dystrophinassociated protein complex (dystrophin, utrophin, and dystrobrevin). The syntrophins are characterized by their domain structure which can contain up to two pleckstrin homology (PH) domains, a class I PDZ domain, and a syntrophin-unique domain (Fig. 8) (44) . The syntrophinunique domain mediates binding of syntrophin to the dystrophin complex. In addition to its interaction with Kir2 channels, the PDZ domain can interact with the muscle and cardiac voltage-gated sodium channels Na v 1.4 and Na v 1.5 (45), neuronal nitric oxide synthase (nNOS) (72) , and aquaporin-4 (AQP-4) (46, 73).
The dystrophin complex has been demonstrated to form a structural link between the actin cytoskeleton and the extracellular matrix and is especially prevalent in muscle cells.
Disruptions in the complex lead to inadequate support for muscle cell membranes and contraction leads to breakdown of the muscle sarcolemma, which is the primary cause of muscular dystrophy (44) . Via the PDZ domain, syntrophins act as a linker of sodium channels, AQP4, and nNOS to the dystrophin complex (45, 46, 72) . The in vivo role of syntrophins as functional scaffolding proteins at the neuromuscular junction has been demonstrated in α1-syntrophin-null mice. These animals display mislocalization of nNOS and AQP4, which is rescued by transgenically expressed full-length but not PDZ-less α1-syntrophin (73) . Recently, it was demonstrated that the specific clustered localization of Kir4.1 in the endfeet of retinal glial cells is dependent on functional dystrophin (Dp71) expression (74, 75) . In addition, AQP-4 expression shows a marked loss from perivascular and subpial membranes as well as increased degradation rate in α-syntrophin knockout mice (46, 76) . This evidence suggests a role for proteins of the DAPC in clustering and anchoring channels at specialized regions of the plasma membrane.
The discovery that Kir2 channels associate with the DAPC led us to investigate the Kir2 distribution in skeletal muscle, a tissue where the DAPC proteins have been well characterized.
We demonstrated the interaction of Kir2 channels with syntrophin in skeletal muscle by coimmunoprecipitation (Fig. 6) . The colocalization experiments demonstrate for the first time that Kir2 channels are located at the NMJ (Fig. 7) . Additionally, we observed colocalization of Kir2.2 with the DAPC at the NMJ (Fig. 7) . These data suggest that syntrophin may be able to link Kir2 channels to the dystrophin complex, immobilizing the channels at the neuromuscular junction by connection of the complex to the actin cytoskeleton and extracellular matrix.
Our GST fusion protein pulldown assay demonstrated that Kir channels with PDZ binding motifs have different inherent abilities to associate with the DAPC and SAP97, CASK and Veli (Fig. 5) . The C-terminus of Kir2.2 associated strongly with both complexes whereas Table 1 : Affigel-GST-Kir2.2 affinity purified brain proteins identified by mass spectrometry. 50 µl Affigel-GST-Kir2.2 and GST-Kir2.2∆3 columns were incubated with ~100 mg detergent solubilized whole rat brain extract, washed extensively, and eluted with the competitive peptide. 90% of the eluate was used for mass spectrometry analysis. Proteins identified from both columns were subtracted (see methods) and the remaining proteins along with the matched peptide sequences are displayed. The remaining 10% of the eluate was separated by SDS-PAGE and silver stained (see Fig. 2A ). Table 2 : Affigel-GST-Kir2.2 affinity purified heart proteins eluted with competitive peptide and identified by mass spectrometry. 50 µl affigel-GST-Kir2.2 and -Kir2.2∆3 columns were incubated with ~100 mg detergent solubilized rat heart extract and analyzed by mass spectrometry as in Table 1 . A fraction of the eluate was separated by SDS-PAGE and silver stained (see Fig. 3A ). Table 3 : Affigel-GST-Kir2.2 affinity purified heart proteins eluted with SDS and identified by mass spectrometry. 50 µl affigel-GST-Kir2.2 and -Kir2.2∆3 columns were incubated with ~100 mg detergent solubilized rat heart extract, washed extensively, eluted with the competitive peptide ( Table 2) , then eluted with SDS. The SDS eluate was analyzed by mass spectrometry. A fraction of the eluate was separated by SDS-PAGE and silver stained (see Fig. 3B ). The remaining 90% of the eluate was used for mass spectrometry analysis (see Table 1 ). The incubated with ~100 mg detergent solubilized rat heart extract, washed extensively, eluted with the competitive peptide, separated by SDS-PAGE and 10% of the eluate was silver stained. The remaining 90% of eluate was used for mass spectrometry analysis (see Table 2 ). B, The remaining protein bound to the columns was eluted with 1% SDS and 10% of the eluate was visualized by SDS-PAGE followed by silver staining. The remaining 90% of eluate was used for mass spectrometry analysis (see Table 3 ). Closed arrowheads indicate protein bands specifically stained in the Kir2.2 lanes eluted with peptide. Open arrowheads indicate protein bands specifically stained in the Kir2.2 lanes eluted with SDS. The predicted molecular masses and/or SDS-PAGE mobilities of proteins identified by mass spectrometry were visually correlated and assigned to silver stained bands specifically eluted from the Kir2.2 column. C, Competitive peptide and SDS eluates from both Kir2.2 and Kir2.2∆3 columns were separated by SDS-PAGE, transblotted to nitrocellulose, and probed with the antibodies indicated at the right. 
